Velphoro

— THERAPEUTIC CATEGORIES —
  • Hyperphosphatemia

Velphoro Generic Name & Formulations

General Description

Sucroferric oxyhydroxide 500mg; chew tabs.

Pharmacological Class

Phosphate binder.

How Supplied

Chew tabs—90

Velphoro Indications

Indications

For control of serum phosphorus levels in patients with chronic kidney disease on dialysis.

Velphoro Dosage and Administration

Adult

Chew, do not swallow whole. Take with meals. Initially 500mg 3 times daily; monitor serum phosphorus levels and titrate dose in decrements or increments of 500mg/day as needed until acceptable serum phosphorus level reached. May titrate as often as weekly.

Children

Not established.

Velphoro Contraindications

Not Applicable

Velphoro Boxed Warnings

Not Applicable

Velphoro Warnings/Precautions

Warnings/Precautions

GI, hepatic, or iron accumulation disorders; monitor effect and iron homeostasis.

Velphoro Pharmacokinetics

See Literature

Velphoro Interactions

Interactions

Separate dosing of doxycycline, acetylsalicylic acid, cephalexin by ≥1hr before Velphoro; levothyroxine by ≥4hrs before. Concomitant drugs with narrow therapeutic index; monitor.

Velphoro Adverse Reactions

Adverse Reactions

Discolored feces, diarrhea, nausea.

Velphoro Clinical Trials

See Literature

Velphoro Note

Not Applicable

Velphoro Patient Counseling

See Literature